SBI Biotech Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of GNKG168 in Patient With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) (NCT01035216) | SBI Biotech Co., Ltd. | 2009-09-01 |
Track SBI Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.